Farsight Genome Systems Revenue and Competitors
Estimated Revenue & Valuation
- Farsight Genome Systems's estimated annual revenue is currently $620k per year.
- Farsight Genome Systems's estimated revenue per employee is $155,000
Employee Data
- Farsight Genome Systems has 4 Employees.
- Farsight Genome Systems grew their employee count by -20% last year.
Farsight Genome Systems's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and founder | Reveal Email/Phone |
Farsight Genome Systems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Farsight Genome Systems?
Farsight Genome Systems has developed an innovative SaaS solution for health systems providing genetic/genomic testing as part of precision medicine programs. The API architecture integrates readily into existing LIS/EMR software, providing enterprise-wide genomic data management with on-demand re-analysis and re-interpretation. End-user laboratories select from a portfolio of in silico, multi-gene Testpanels to control indication-specific analysis and reporting. The Farsight Genome Systems solution accelerates adoption of recommended genomic testing from evidence-based clinical practice guidelines.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 4 | -33% | $80M |
#2 | $0.5M | 4 | N/A | N/A |
#3 | $0.3M | 4 | N/A | N/A |
#4 | $0.3M | 4 | N/A | N/A |
#5 | $0.3M | 4 | N/A | N/A |